These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 16236493)

  • 1. Prevention and treatment of pregnancy-induced hypertension (preeclampsia) with progestogens.
    Sammour MB; el-Kabarity H; Fawzy MM; Schindler AE
    J Steroid Biochem Mol Biol; 2005 Dec; 97(5):439-40. PubMed ID: 16236493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Present and future aspects of dydrogesterone in prevention or treatment of pregnancy disorders: an outlook.
    Schindler AE
    Horm Mol Biol Clin Investig; 2016 Aug; 27(2):49-53. PubMed ID: 27662647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful prevention of preeclampsia in a high-risk pregnancy using progestogen dydrogesterone: a clinical case.
    Tskhay VB; Kovtun NM; Schindler AE
    Horm Mol Biol Clin Investig; 2016 Sep; 27(3):85-8. PubMed ID: 27383893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review on role of progestogen (dydrogesterone) in the prevention of gestational hypertension.
    Mohamad Razi ZR; Schindler AE
    Horm Mol Biol Clin Investig; 2016 Aug; 27(2):73-6. PubMed ID: 27101553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dydrogesterone support following assisted reproductive technique (ART) reduces the risk of pre-eclampsia.
    Ali AB; Ahmad MF; Kwang NB; Shan LP; Shafie NM; Omar MH
    Horm Mol Biol Clin Investig; 2016 Sep; 27(3):93-6. PubMed ID: 26910749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progestogens for treatment and prevention of pregnancy disorders.
    Schindler AE
    Horm Mol Biol Clin Investig; 2010 Dec; 3(3):453-60. PubMed ID: 25961219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dydrogesterone and the immunology of pregnancy.
    Raghupathy R; Szekeres-Bartho J
    Horm Mol Biol Clin Investig; 2016 Aug; 27(2):63-71. PubMed ID: 26812877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pilot study to determine whether progestogen supplementation using dydrogesterone during the first trimester will reduce the incidence of gestational hypertension in primigravidae.
    Zainul Rashid MR; Lim JF; Nawawi NH; Luqman M; Zolkeplai MF; Rangkuty HS; Mohamad Nor NA; Tamil A; Shah SA; Tham SW; Schindler AE
    Gynecol Endocrinol; 2014 Mar; 30(3):217-20. PubMed ID: 24552449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New data about preeclampsia: some possibilities of prevention.
    Schindler AE
    Gynecol Endocrinol; 2018 Aug; 34(8):636-637. PubMed ID: 29508649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of progestogens for the prevention of premature birth.
    Schindler AE
    J Steroid Biochem Mol Biol; 2005 Dec; 97(5):435-8. PubMed ID: 16198556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomised controlled double-blind clinical trial of 17-hydroxyprogesterone caproate for the prevention of preterm birth in twin gestation (PROGESTWIN): evidence for reduced neonatal morbidity.
    Awwad J; Usta IM; Ghazeeri G; Yacoub N; Succar J; Hayek S; Saasouh W; Nassar AH
    BJOG; 2015 Jan; 122(1):71-9. PubMed ID: 25163819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progesterone is not the same as 17α-hydroxyprogesterone caproate: implications for obstetrical practice.
    Romero R; Stanczyk FZ
    Am J Obstet Gynecol; 2013 Jun; 208(6):421-6. PubMed ID: 23643669
    [No Abstract]   [Full Text] [Related]  

  • 13. 17alpha-hydroxyprogesterone caproate for the prevention of preterm delivery: A cost-effectiveness analysis.
    Odibo AO; Stamilio DM; Macones GA; Polsky D
    Obstet Gynecol; 2006 Sep; 108(3 Pt 1):492-9. PubMed ID: 16946206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does progesterone treatment influence risk factors for recurrent preterm delivery?
    Meis PJ; Klebanoff M; Dombrowski MP; Sibai BM; Leindecker S; Moawad AH; Northen A; Iams JD; Varner MW; Caritis SN; O'Sullivan MJ; Miodovnik M; Leveno KJ; Conway D; Wapner RJ; Carpenter M; Mercer B; Ramin SM; Thorp JM; Peaceman AM; Gabbe S
    Obstet Gynecol; 2005 Sep; 106(3):557-61. PubMed ID: 16135587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of dydrogesterone on the vascular system.
    Seeger H; Mueck AO
    Gynecol Endocrinol; 2007 Oct; 23 Suppl 1():2-8. PubMed ID: 17943533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dydrogesterone and pre-term birth.
    Hudic I; Schindler AE; Szekeres-Bartho J; Stray-Pedersen B
    Horm Mol Biol Clin Investig; 2016 Sep; 27(3):81-3. PubMed ID: 26812800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short- and long-term strategies for the management of hypertensive disorders of pregnancy.
    Huda SS; Freeman DJ; Nelson SM
    Expert Rev Cardiovasc Ther; 2009 Dec; 7(12):1581-94. PubMed ID: 19954320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is 17α-hydroxyprogesterone caproate contraindicated in twin gestations?
    Romero R; Conde-Agudelo A
    BJOG; 2015 Jan; 122(1):6-7. PubMed ID: 25280114
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of progestogen supplementation (dydrogesterone) in the prevention of preeclampsia.
    Tskhay V; Schindler A; Shestakova M; Klimova O; Narkevich А
    Gynecol Endocrinol; 2020 Aug; 36(8):698-701. PubMed ID: 31876197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of progesterone signaling during pregnancy: implications for the use of progestins for the prevention of preterm birth.
    Byrns MC
    J Steroid Biochem Mol Biol; 2014 Jan; 139():173-81. PubMed ID: 23410596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.